{"nct_id":"NCT03726333","title":"Hepatic Impairment Study for Lorlatinib in Cancer Patients","status":"TERMINATED","status_verified_date":"2024-01","start_date":"2020-01-14","start_date_type":"ACTUAL","primary_completion_date":"2021-07-08","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["PFE"]}